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Rat and Human Liver Cytosolic Epoxide
Hydrolases: Evidence for Multiple Forms at
the Level of Protein and mRNA
by Helmut Thomas,* Ludwig Schladt,* Johannes
Doehmer,* Michael Knehr,* and Franz Oesch*
Two forms of human liver cytosolic epoxide hydrolase (cEH) with diagnostic substrate specificity for
trans-stilbene oxide (cEHTso) and cis-stilbene oxide (cEHcso) have been identified, and cEHcso was
purified to apparent homogeneity. The enzyme had a monomer molecular weight of 49 kDa and an isoe-
lectric point of9.2. PurecEHcso hydrolyzed CSO at arate of145 nmole/min/mg. TSO was not metabolized
at a detectable level, and like cEHTso, the enzyme was about three times more active at pH 7.4 than at
pH 9.0. Unlike cEHrso, cEHcso was efficiently inhibited by 1 mM 1-trichloropropene oxide (90.5%) and
1 mM STO (92%). Similarly, liver cEH purified 541-fold from fenofibrate induced Fischer 344 rats was
shown to be a native 120 kDa dimer of two 61 kDa subunits. The enzyme expressed maximum activity of
205 nmole/min/mg at pH 7.4 toward the diagnostic substrate TSO with an apparent Km of 1.7 ,M. In
Western blots, polyclonal antibodies against rat livercEH were shown torecognize asingle 61 kDaprotein
band from liver cytosol ofrat, mouse, guinea pig, Syrian hamster, and rabbit. This antibody precipitated
neither human livercEHTso orcEHcso. Antibodies against rat livermicrosomal epoxide hydrolase reacted
with cEHcso in the Western blot and on immunoprecipitation. Using antibodies against rat liver cEH, 24
positive clones were picked upon colony blot screening of a pEX 1IE. coli POP 2136 expression library.
After Northern blotting against rat liver total RNA, clone 24 recognized a second mRNA-species besides
the putative message for cEHTso, thus providing strong evidence for the multiplicity of rat liver cEH as
well. The importance ofthesefindingsforthecontrol ofreactive metabolites ofvariousorigins isdiscussed.
Introduction
Epoxides are formed in vivo mainly by the microso-
mal cytochrome P-450-dependent monooxygenase sys-
tem. Epoxides have been identified as intermediates of
arachidonic acid (1) and steroid (2) metabolism as well
asproducts offatty acidperoxidation (3). Epoxides have
also been identified as metabolites of numerous xeno-
biotic compounds containing olefinic or aromatic double
bonds (4). Due to their electrophilicity, epoxides may
bind covalently to cellular nucleophiles such as proteins
and nucleic acids and thus elicit toxic, mutagenic or
carcinogenic effects (5).
Enzymatic inactivation of reactive epoxides is pro-
vided in part by conjugation to glutathione (6) or the
addition of water by epoxide hydrolases. Epoxide hy-
drolases (EC 3.3.2.3) constitute a family of enzymes
comprising at least three major forms. The major forms
have been characterized as distinctproteins onthe basis
of subcellular localization, molecular weight, optimum
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pH, substrate specificity, immunological properties, in-
hibition, and different response.to known inducers (7).
Purified microsomal epoxide hydrolase (mEHb) has a
molecularweight ofabout 50kDaandhydrolyzes awide
variety of cyclic epoxides such as phenanthrene-9,10-
oxide and benzo(a)pyrene-4,5-oxide (8) as well as mono-
and cis-1,2-disubstituted oxiranes (9). Microsomal cho-
lesterol epoxide hydrolase (mEHCh) is distinguished by
its narrow substrate specificity for physiologically aris-
ing 5,6-epoxy-cholesterol and its derivatives (10).
In contrast, epoxides on cyclic systems are poor sub-
strates for cytosolic epoxide hydrolase (cEH), which
appears to be localized in peroxisomes as well as in the
cytosol (11). This enzyme rapidly hydrolyzes aliphatic
oxiranes, such as epoxides ofcis- and trans-unsaturated
fatty acids, including arachidonic acid, squalene oxides,
and side chain epoxidized sterols (7). A diagnostic in
vitro substrate for cEH is trans-stilbene oxide (TSO),
which is neither metabolized by mEHb nor mEHCh.
Conversely, benzo(a)pyrene-4,5-oxide and styrene ox-
ide (STO) are used as selective substrates for mEHb.
Most of our knowledge about cEH has been gained
from studies on the purified enzymes from mouse and
rabbit liver (12). These two species, together with the
hamster, possess by far the highest TSO-hydrolyzingTHOMAS ETAL.
activity of all investigated species (165-335 nmole/min
x g liver and 106-129 nmole/min x g liver compared
to human and rat liver with 15-22 nmole/min x g and
10-15 nmole/min x g, respectively) (13). The low spe-
cific cytosolic activity of rat and human liver cEH as
well as the strong inducibility of the rat liver enzyme
by hypolipidemic drugs with peroxisome proliferating
activity suggested that these enzymes differ in prop-
erties and regulation and that rat liver cEH may ac-
tuallybeassociated withperoxisomes andplayadistinct
role in the metabolic processes of this subcellular par-
ticle.
The different properties of cEH and mEHb as well
as the substantial differences among cEH activities in
various species suggest that there are differences in
detoxification capacities and protection of subcellular
compartments from reactive epoxides. The largely un-
known properties of human liver cEH make extrapo-
lationoffunctionalparameters andriskassessmentwith
respect to environmental toxicants difficult. This inves-
tigation was therefore directed toward elucidating pos-
siblemultiplicities ofcEH inrats and humans, the prop-
erties ofthese isoenzymes, and their contribution tothe
cellular protection against reactive epoxides.
Purification of Rat and Human Liver
cEH
Cytosolic epoxide hydrolase was purified to apparent
homogeneity from fenofibrate-induced rat liver (14).
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Throughout the purification, enzyme activity was mon-
itored with the substrates STO, CSO, TSO, and TESO,
and there was no evidence from the elution profiles for
activities other than STO, TSO, or TESO hydrolases,
which coincided in all chromatograms. Also, the puri-
fication factors of423, 541, and 485 for STO, TSO, and
TESO hydrolase activity, respectively, were of the
same order ofmagnitude. Additionally, cEH activity of
untreated and induced animals expressed identical elu-
tion behavior in the corresponding chromatography
steps. Further comparing the specific activity toward
TSO ofpurified cEH from induced animals (173 nmole/
min x mg) with 62 nmole/min x mg for the estimated
30% pure enzyme from controls indicated that the two
enzyme forms were identical. There was no evidence
for amultiplicity ofcEH inratliveratthe proteinlevel.
Investigation ofhuman livercEH fromcytosolrevealed
that CSO, which is regarded a diagnostic substrate for
mEHb, was hydrolyzed at the considerable rate ofabout
1.3 nmole/min x mg, which is slightly higher than the
turnoverbymonkey(Macacafascicularis) and morethan
10 times higher than the hydration of CSO by rat liver
cytosol (13). Isoelectric focusing confirmed the existence
of two distinct human liver cytosolic epoxide hydrolases
for the hydration of CSO (cEHcso) and TSO (cEHrso),
and the specificities of both proteins were mutually ex-
clusive. cEHrso was very unstable and could only be par-
tially purified by anion exchange chromatography and gel
filtration (Fig. 1).
In contrast, cEHcso was purified 85-fold to apparent
homogeneity from 60 g ofliver rom a 23-year-old male
organ donor who had died in an accident (15) (Fig. 2).
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FIGURE 1. Fractionation ofhuman liver cytosolic epoxide hydrolase by anion-exchange chromatography. Cytosolic protein, 8 mg, was frac-
tionated on a Mono Q column (FPLC) at a flow rate of 1 mL/min, and eluates were assayed forepoxide hydrolase activity toward CSO and
TSO.
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Biochemical Properties of Purified
Rat and Human Liver cEH
Native rat liver cEH elutes as a protein ofmolecular
weight 120 kDa during gel filtration on Sephadex G-150
andyields asinglebandafterSDS-PAGE corresponding
to a molecular weight of60 kDa. This suggests a native
dimer of two closely related, if not identical, subunits
(14) (Fig. 2).
Similarly, gel filtration ofhuman liver cytosol on Su-
perose-12 revealed a native molecular weight of ap-
proximately 130 kDa for TSO-hydrolyzing activity,
which is close to 140 kDa reported by Wang et al. (16)
for purified -human liver cEHTESO. Native cEHcso
eluted essentially with the void volume, indicating the
formation ofhigh molecular weight aggregates that are
resolved on SDS-PAGE into a single protein band of
molecular weight 49 kDa (Fig. 2). This behavior resem-
bles closely that ofmEHb from all species investigated
sofar (7). However, thepI of9.2forcEHcsois different
from pI 7.0 for human liver mEHb and pI 5.7 for
cEHTSO. Also, the optimum pH forcEHcso of7.4 is far
from pH 9.0, which is known as the pH optimum for
mEHb, and it is identical with the pH optimum of 7.4
A. U.J....c.::: :. .
FIGURE 2. SDS-polyacrylamide gel electrophoresis of purified hu-
man liver cEHcso. Rat liver mEHb, 7,ug (lane A) 1 jig ofrat liver
cEH (lane B), and 1.5 ,ug purified human liver cEHcso (lane C)
were electrophoresed in a 12% slab gel according to Laemmli (21)
and stained with Coomassie brilliant blue R-250.
Table 1. Effect ofdifferent modulators on the activity of human
liver cytosolic epoxide hydrolase.
Epoxide hydrolase activity, % control
Microsomal with cEHcso cEHTso
Modulator STO CSO with CSOa with TSO"
TCPO 2 5 9.5 69
Benzil 219 49 74 68
1-Benzylimidazole 224 38 91 105
Chalcone 107 48 60 52
STO 54 1 8 90
aActivitiesofcEHcsoand cEHTSOweredeterminedafterseparation
by anion exchange chromatography as described by Schladt et al. (15).
Incubations contained the individual compounds at a concentration of
1 mM.
for rat liver cEH (14) and human liver cEHTSO. A re-
lationship of cEHcso to the classical cytosolic epoxide
hydrolases may be deduced from a similar response of
cEHcso to the inhibitors benzil, 1-benzylimidazole, and
chalcone, whereas inhibition of cEHcso by TCPO or
STO would rather argue for a mEHb-like isoenzyme
(Table 1).
Unlike purified mouse liver cEH, which readily hy-
drates CSO at a rate of 136 nmole/min x mg, approx-
imatelyone-sevenththerate ofTSO-hydrolysis (17), rat
livercEH does not metabolize CSO at adetectable level
and hydrates TSO at a rate of 173 nmole/min x mg in
the presence of 26 ,uM substrate. The corresponding
apparent Km and Vmax values were determined from
Lineweaver-Burk plots as 1.7 ,uM and 205 nmole/min
x mg, respectively.
Purified human livercEHcso, onthe otherhand, con-
verts CSO at a rate of145 nmole/min x mg, like mouse
liver cEH, but does not accept TSO as a substrate.
Partially purified cEHTso does not metabolize STO, in
contrastto purified mouse (17) and ratlivercEH aswell
as human liver cEHTESO (16) and cEHcso.
Immunological Properties of Rat
and Human Liver cEH
With polyclonal antibodies against purified rat liver
cEH, asingle band was obtained afterWesternblotting
of purified rat liver cEH and cytosol from control as
well as clofibrate-induced animals. Strong induction of
this enzymebythehypolipidemic compound wasclearly
demonstrated (Fig. 3A). The antibody also recognized
proteins with a molecular weight ofabout 60 kDa (cor-
responding to rat liver cEH) from liver cytosols of
mouse, Syrian hamster, and New Zealand white rabbit
(Figs. 4C,E,F). The reaction with guinea pig liver cy-
tosol (Fig. 4D) was very weak, and there was no cross-
reactivity with liver cytosol from green monkey (Fig.
4G). The two low molecular weight proteins in Syrian
hamstercytosolthatweredistinguished bytheantibody
may be products ofcEH-proteolysis.
Immunoprecipitationwithantiserumagainstratliver
cEH demonstrated essentially 100% removal from rat
liver and kidney cytosol of TSO hydrolyzing activity,
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FIGURE 3. Western blotting of rat (A) and human liver (B) epoxide
hydrolases. (A) Purified rat liver cEH, 0.16 pg (lane A); 100 ,ig
each of liver cytosol from untreated rats (lane B) and clofibrate-
induced rats (0.25% for 1 week in the diet) (lane C) was transferred
to nitrocellulose following SDS-PAGE and stained with rabbit
anti-rat liver cEH antibodies as described by Towbin (22). (B)
Immunoblotting of 0.9 p.g purified rat liver mEHb (lane A) and
.1.5 jig cEHlcso with anti-rat liver mEHb antibodies (lane B).
whereas human liver cEHTSO was not precipitated at
all, and precipitation of cEHcso did not exceed 20% of
the initial activity even at the highest antiserum con-
centration (14,15). However, essentially all human liver
cytosolic CSO hydrolase as well as STO hydrolase ac-
tivity was precipitated with a polyclonal antibody
against purified rat liver mEHb, while the TSO-hydro-
lyzing activity remained unaffected.
Although the immunological relationship of rat liver
mEHb and cEHcso was confirmed by Western blotting,
the small degree of similarity was underlined by the
weak response of about one-tenth the signal intensity
at 7.7 times the protein concentration (Fig. 3B).
From these immunological investigations one can con-
clude that rat, mouse, hamster, and rabbit liver as well
as rat kidney TSO-hydrolase activities reside on struc-
turally related proteins. On the other hand, human liver
cEHTso and cEHcso as well as green monkey and
guinea pig liver cytosolic TSO-hydrolase appear to be
structurally completely different from rat liver cEH. A
distant, but definite structural relationship of rat liver
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FIGURE 4. Western blotting of cytosolic epoxide hydrolases from
different species. Purified rat liver cEH, 0.16 jig (lane A) and 100
p.g each ofliver cytosol from control rat (lane B), mouse (lane C)
guinea pig (lane D), Syrian hamster (lane E), rabbit (lane F), and
greenmonkey(lane G)wastransferredtonitrocelluloseafterSDS-
PAGE and stained with rabbit anti-rat liver cEH antibodies.
mEHb with human liver cEHcso could be demon-
strated.
cDNA Cloning of Rat Liver cEH
A cDNA expression library was constructed using
purified poly-A mRNA from tiadenol-induced rat liver
inthe plasmid pEX1/E. coli POP2136system according
to Haymerle et al. (18) and screened by a colony blot
hybridization procedure with polyclonal antibodies
against rat liver cEH (19). Twenty-four positive clones
wereconfirmeduponrescreening, andthecDNAinserts
ofthe four biggest clones, ranging between 0.8 and 1.2
kb, were verified by cross-hybridization using Southern
and Northern blotting against three independent total
RNA preparations from untreated, Aroclor 1254- and
tiadenol-induced rat livers (Fig. 5).
In Northern blotting, all clones recognized the same
mRNA, which is believed to be the coding mRNA for
rat liver cEH. Additionally, clone 24 picked up a second
mRNA species, somewhat smaller than the putative
mRNA for cEH. This result may indicate for the first
time the existence of a second isoenzyme ofcEH in rat
liver, which may be related to human liver cEHcso.
However, this activity has not been allocated as yet to
a distinct rat cytosolic protein, although minute CSO-
hydrolyzing activities ofabout 0.1 nmole/min x g have
been described in rat liver (13). Recently, a cytosolic
hepoxilin epoxide hydrolase with molecular weight 53
kDa and marginal activity toward STO was isolated
from rat liver (20) and may correspond to the newly
identified mRNA.
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FIGURE 5. Hybridization of cDNA inserts from positive cEH clones with total rat liver RNA. Total RNA from control (lane A), Aroclor
1254-induced (lane B), and Tiadenol-induced (lane C) rat liver was subjected in four identical sets (I-IV) to denaturing 0.7% agarose gel
electrophoresis, transferred to nitrocellulose sheets and hybridized with [32P]-labeled cDNA probes from clones 7 + 14 (I); 14 + 15 (II);
14 + 24 (III); and 7, 14, 15, 24 (IV). Hybridization was visualized by autoradiography.
Table 2. Classification of cytosolic epoxide hydrolases from different species according to physical, biochemical, and
immunological properties.
Activity towarda Cross-reactivity with antiserum against'
Class Species TSO CSO STO MW pI cEH mEHb~ Reference
I Mouse liver 939-1500 136-180 475-622 59000 5.5 + - (17,23,24)
Rat liver 173 NDc 1567 61000 5.5 + - (14)
Rabbit liver 0.69-0.93d NM 1380 57000 6.0 + - (25)e
Hamster liver 2.10-2.20d 0.11-0.15d NM 57000 NM + - (13)r
II Guinea pig liver 0.87-0.99d 0.15-0.21d NM 57000 7.4 - - (13)e
Monkey liver 0.36-0.44d 0.94-0.96d NM 58000 NM - - (13)"
Human liver cEHTSO 1.02f 0.32 ND NM 5.7 - - (15)
Human liver cEHTESO 150 NM 22 58000 5.1-6.1 - - (15,16)
III Human liver cEHcso ND 145 ND 49000 9.2 - + (15)
Human liver cEHpNso 14 NM 44 50000 NM - + (16)
aActivities are given in nmole/min/mg.
b(+) Indicates weak but clearly detectable cross-reactivity; (-) indicates very faint reactivity CND, not detectable; NM, not measured.
dActivities were determined from cytosol.
eSee also Figure 4.
fActivity after anion exchange chromatography ofcytosol.
Conclusions
Twoforms ofhuman liver cEH, cEHcso, and cEHTSO
have been identified, and cEHcso as well as rat liver
cEH have been purified to apparent homogeneity. An
attempt has been made to assign these enzyme forms
to three classes (Table 2) according to their physical,
biochemical, and immunological properties, taking into
account the known properties of cEH from other spe-
cies.
Class I cEH isoenzymes are characterized by im-
munologicalcross-reactivitywitheithercEH-antiserum
against any member of this group and diagnostic sub-
strate specificity toward TSO, STO,and with some lim-
itations, towards CSO. Mouse, rat, rabbit, and hamster
liver cEH meet these requirements. Class II comprises
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Table 3. Metabolism of methylated styrene oxides by rat and human liver cytosol and microsomes.a
Microsomes Cytosol Microsomes/cytosol
Substrate Rat Human Rat Human Rat Human
Styrene oxide 4.300 40.7 0.300 5.600 14.3 7.3
trans-2-Methyl styrene oxide NMb 86500.0 NM 2100.0 NM 41.2
cis-2-Methylstyrene oxide 0.260 5.4 0.010 0.664 26.0 8.1
trans-1,2-Dimethyl styrene ND 0.238 ND ND -c
oxide
cis-1,2-Dimethyl styrene oxide 0.08 0.665 ND 0.034 19.6
2,2-Dimethyl styrene oxide 0.007 0.130 0.001 0.122 7.0 1.1
aActivities were determined at 0.5 mM substrate concentration as described by Milbert et al. (26) and are given in nmole/min/mg.
bNM, not measured; ND, not detectable.
'Ratio cannot be formed because one ofthe values is-zero.
guinea pig, monkey, and human liver cEHTSO as well
as human cEHTESO, which have diagnostic substrate
specificity for TSO and low turnover rates with CSO
(13). No cross-reactivity is observed among members
ofthis class with antiserum against cEH ormEHb from
either species of group I. Class III isoenzymes, which
are represented by human livercEHcso and cEHPNSO,
have lower molecular weights than the TSO-hydrolases
of classes I and II and express an immunological rela-
tionship with antibodies against mEHb ofeither source.
From this classification it appears that the structural
and functional multiplicity of cEH increases with phy-
logenetic differentiation. The possible impact of this
cEH differentiation on the celiular protection against
reactive epoxides was investigated with differentially
methylated styrene oxides and microsomes or cytosol
as enzyme source (Table 3). Human enzymes of either
sourcemetabolized allmodelsubstratesmoreefficiently
than the corresponding rat liver enzymes. The ratio of
microsomal/cytosolic hydration for a certain substrate
isclearlyshiftedtowardtwotoseventimeslowervalues
in humans. This finding can be explained by the pres-
ence of cEHcso, which provides mEHb-like detoxifi-
cation capacities particularly for cis-substituted epox-
ides such as cis-2-methyl styrene oxide, cis-1,2-
dimethylstyrene oxide, and 2,2-dimethyl styrene oxide.
In conclusion, a multiplicity of human as well as rat
liver cEH could be demonstrated at the enzyme level
for the human, and at the mRNA level for rat liver
cEH. However, due to human liver cEHcso, this mul-
tiplicity appears much more effective in humans than
in rats for the protection of different subcellular com-
partments against reactive epoxides, and human liver
seems to be far more efficient in detoxification of re-
active epoxides by epoxide hydrolase. Rat liver may
therefore not be an appropriate model for epoxide hy-
drolase-related risk assessment in humans.
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